Estimates Revisions CSPC Pharmaceutical Group Limited

Stocks

Delayed Hong Kong S.E. Other stock markets 04:29:11 27/07/26 pm AEST			5-day change	1st Jan Change
8.370 ^HKD	-2.11%		-1.65%	-0.83%

24/07	CSPC Pharmaceutical Group Limited Announces Marketing Approval For Paliperidone Palmitate Injection	CI
23/07	CSPC Pharmaceutical Group Limited Initiates Phase II Clinical Trial of Sys6026 Injection for HPV Type 16 or 18 Related Cervical High Grade Squamous Intraepithelial Lesion in China	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	CSPC PHARMACEUTICAL GROUP LIMITED
	ELI LILLY AND COMPANY
	JOHNSON & JOHNSON
	ABBVIE INC.
	ROCHE HOLDING AG
	NOVARTIS AG
	ASTRAZENECA PLC
	NOVO NORDISK A/S
	AMGEN INC.
	GILEAD SCIENCES, INC.
	Average
	Weighted average by Cap.